Karuna Therapeutics to Present at the Citi 16th Annual BioPharma Virtual Conference

Rhea-AI Summary

Karuna Therapeutics (NASDAQ: KRTX) has announced that CEO Steve Paul will participate in a panel discussion titled “Emerging Therapies for Psychiatric Disorders” at the Citi 16th Annual BioPharma Virtual Conference on September 8, 2021, at 10:40 a.m. ET. A live webcast will be available on the Investor Relations page of Karuna’s website, with a replay archived for up to 30 days. As a clinical-stage biopharmaceutical company, Karuna is focused on developing transformative treatments for psychiatric and neurological conditions.

BOSTON--(BUSINESS WIRE)-- Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that Steve Paul, M.D., chief executive officer, president and chairman, will participate in a panel titled “Emerging Therapies for Psychiatric Disorders” at the Citi 16^th Annual BioPharma Virtual Conference on September 8, 2021, at 10:40 a.m. ET.

A live webcast of the presentation will be available on the Investor Relations page of Karuna’s website at investors.karunatx.com. A replay of the webcast will also be archived for up to 30 days on Karuna’s website following the conference.

About Karuna

Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions. At Karuna, we understand there is a need for differentiated and more effective treatments that can help patients navigate the challenges presented by these severe and disabling disorders. Utilizing our extensive knowledge of neuroscience, we are harnessing the untapped potential of the brain in pursuit of novel pathways to develop medicines that make meaningful differences in peoples’ lives. For more information, please visit www.karunatx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210831005115/en/

Investors:

Alexis Smith

518-338-8990

asmith@karunatx.com

Source: Karuna Therapeutics, Inc.

FAQ

What event will Karuna Therapeutics be participating in?

Karuna Therapeutics will participate in the Citi 16th Annual BioPharma Virtual Conference.

Who from Karuna Therapeutics is speaking at the conference?

Steve Paul, CEO of Karuna Therapeutics, will speak at the conference.

When is the Citi BioPharma Virtual Conference scheduled?

The conference is scheduled for September 8, 2021.

What time will the panel on Emerging Therapies for Psychiatric Disorders take place?

The panel will take place at 10:40 a.m. ET.

Where can I watch the Karuna Therapeutics conference presentation?

The presentation will be available via a live webcast on Karuna’s Investor Relations page.